Clinical Trial Update: Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating DPPG2-TSL-DOX in combination with hyperthermia for soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• DPPG2-TSL-DOX (doxorubicin-loaded temperature-sensitive liposome)

Snippet

Sponsor: Thermosome GmbH | Conditions: Sarcoma, Soft Tissue | Phase 1 | Status: COMPLETED